Value of serum carbohydrate antigen 19-9, endothelial cell specific molecule 1 and C-reactive protein to albumin ratio in diagnosis and evaluating prognosis of colorectal cancer

PAN Yan; LI Runpu; XU Yangtao; WANG Yanli; TIAN Zhigang; MA Shenghui

doi:10.7619/jcmp.20213151

Journal of Clinical Medicine in Practice > 2022 > 26(3): 95-100. > DOI: 10.7619/jcmp.20213151

PAN Yan, LI Runpu, XU Yangtao, WANG Yanli, TIAN Zhigang, MA Shenghui. Value of serum carbohydrate antigen 19-9, endothelial cell specific molecule 1 and C-reactive protein to albumin ratio in diagnosis and evaluating prognosis of colorectal cancer[J]. Journal of Clinical Medicine in Practice, 2022, 26(3): 95-100. DOI: 10.7619/jcmp.20213151

Citation:

PDF (1448 KB)

Value of serum carbohydrate antigen 19-9, endothelial cell specific molecule 1 and C-reactive protein to albumin ratio in diagnosis and evaluating prognosis of colorectal cancer

1.
Department of Oncology, the Second Central Hospital of Baoding City in Hebei Province, Baoding, Hebei, 072750
2.
Department of Urinary Surgery, the Second Central Hospital of Baoding City in Hebei Province, Baoding, Hebei, 072750
3.
Department of Laboratory Medicine, the Second Central Hospital of Baoding City in Hebei Province, Baoding, Hebei, 072750
4.
Department of Oncology Surgery, Chengde Central Hospital in Hebei Province, Chengde, Hebei, 067000

More Information

Received Date: August 04, 2021
Available Online: March 10, 2022
Published Date: February 14, 2022

Graphical Abstract

Abstract

Abstract

Objective To analyze the diagnostic value of serum carbohydrate antigen 19-9 (CA19-9), endothelial cell specific molecule 1 (ESM-1) and ratio of C-reactive protein (CRP) to albumin (ALB) in colorectal cancer and their relationships with clinicopathological features and survival time.
Methods Eighty-six patients with colorectal cancer were selected as colorectal cancer group, 50 patients with concurrent colorectal benign lesions were selected as benign lesion group, and 50 healthy subjects were selected as control group. Serum CA19-9, ESM-1 and CRP/ALB in three groups were detected; postoperative survival of colorectal cancer patients were followed up; diagnostic efficacy of CA19-9, ESM-1, CRP/ALB in colorectal cancer and their relationships with clinicopathological features and survival time were analyzed; prognostic risk factors were analyzed.
Results Serum CA19-9 and ESM-1 levels in the colorectal cancer group were significantly higher than those in the benign lesion group and control group (P < 0.05); the CRP/ALB in the colorectal cancer group was significantly higher than that in the benign lesion group, and was significantly higher in the benign lesion group than that in the control group (P < 0.05). The area under curve (AUC) of combined diagnosis of CA19-9, ESM-1 and CRP/ALB for colorectal cancer was 0.961, the sensitivity was 94.18%, and the specificity was 85.75%. CA19-9 was correlated with lymph node metastasis and distant metastasis (P < 0.05); ESM-1 was correlated with TNM stage and distant metastasis (P < 0.05); CRP/ALB was correlated with tumor differentiation, TNM stage, lymph node metastasis and distant metastasis (P < 0.05). The median survival time of patients with high levels of CA19-9, ESM-1 and CRP/ALB was significantly shorter than that of patients with low levels (P < 0.05). The degree of differentiation, TNM stage, distant metastasis, CA19-9, ESM-1 and CRP/ALB were prognostic influencing factors for colorectal cancer (P < 0.05).
Conclusion The joint detection of serum CA19-9, ESM-1 and CRP/ALB has a high diagnostic efficiency for colorectal cancer. They are all closely related to the occurrence and development of colorectal cancer, and affect the prognosis of patients.

FullText(HTML)

References (26)

References

[1]	WONG S H, YU J. Gut microbiota in colorectal cancer: mechanisms of action and clinical applications[J]. Nat Rev Gastroenterol Hepatol, 2019, 16(11): 690-704. doi: 10.1038/s41575-019-0209-8
[2]	WANG G, FU S, LI D C, et al. Expression and clinical significance of serum NT5E protein in patients with colorectal cancer[J]. Cancer Biomark, 2019, 24(4): 461-468. doi: 10.3233/CBM-182207
[3]	FAHRMANN J F, SCHMIDT C M, MAO X Y, et al. Lead-time trajectory of CA19-9 as an anchor marker for pancreatic cancer early detection[J]. Gastroenterology, 2021, 160(4): 1373-1383, e6. doi: 10.1053/j.gastro.2020.11.052
[4]	李世龙, 张宝, 宋扬, 等. 血清ESM-1和CEA及CA199检测对结直肠癌诊断价值探讨[J]. 中华肿瘤防治杂志, 2019, 26(15): 1119-1123.
[5]	余中林, 周业江. 基于CRP的炎症指标与进展期胃癌预后的相关性分析[J]. 中国免疫学杂志, 2020, 36(5): 618-624. doi: 10.3969/j.issn.1000-484X.2020.05.019
[6]	田山, 曹英豪, 廖斐, 等. 术前C反应蛋白与前白蛋白比值预测结直肠癌患者术后预后的价值[J]. 中华消化杂志, 2021, 41(3): 195-199. doi: 10.3760/cma.j.cn311367-20200811-00481
[7]	乔乐乐, 王公平, 周博, 等. 胃癌患者术前CRP/Alb比与淋巴结转移相关性的研究[J]. 中国肿瘤临床, 2017, 14(5): 210-213. doi: 10.3969/j.issn.1000-8179.2017.05.246
[8]	国家卫生和计划生育委员会《中国结直肠癌诊疗规范(年版)》专家组. 中国结直肠癌诊疗规范(2017年版)[J]. 中华临床医师杂志: 电子版, 2018, 12(1): 3-23. doi: 10.3877/cma.j.issn.1674-0785.2018.01.003
[9]	YAMASHITA S, PASSOT G, ALOIA T A, et al. Prognostic value of carbohydrate antigen 19-9 in patients undergoing resection of biliary tract cancer[J]. Br J Surg, 2017, 104(3): 267-277. doi: 10.1002/bjs.10415
[10]	张辉, 姚士伟, 崔培林, 等. 66例血清CA19-9异常高值患者的病因分析[J]. 山东医药, 2018, 58(35): 78-80. doi: 10.3969/j.issn.1002-266X.2018.35.021
[11]	LI C, GENG H, JI L H, et al. ESM-1: a novel tumor biomaker and its research advances[J]. Anti Cancer Agents Med Chem, 2019, 19(14): 1687-1694. doi: 10.2174/1871520619666190705151542
[12]	SHEN Y J, WANG H G, LI W D, et al. Prognostic significance of the CRP/Alb and neutrophil to lymphocyte ratios in hepatocellular carcinoma patients undergoing TACE and RFA[J]. J Clin Lab Anal, 2019, 33(9): e22999.
[13]	WU T T, MO Y L, WU C T. Prognostic values of CEA, CA19-9, and CA72-4 in patients with stages Ⅰ-Ⅲ colorectal cancer[J]. Int J Clin Exp Pathol, 2020, 13(7): 1608-1614.
[14]	HIDAKA E, MAEDA C, NAKAHARA K, et al. High serum CA19-9 concentration predicts poor prognosis in elderly patients with stage Ⅳ colorectal cancer[J]. Gastrointest Tumors, 2018, 5(3/4): 117-124.
[15]	LU G J, SHAO C J, ZHANG Y, et al. Diagnostic and prognostic values of endothelial-cell-specific molecule-1 with malignant pleural effusions in patients with non-small cell lung cancer[J]. Oncotarget, 2017, 8(30): 49217-49223. doi: 10.18632/oncotarget.17455
[16]	李伟娟. 血清P53、ESM-1水平与胃癌晚期化疗患者预后的相关性[J]. 临床医学, 2021, 41(5): 38-40. https://www.cnki.com.cn/Article/CJFDTOTAL-EBED202105015.htm
[17]	YANG W E, HSIEH M J, LIN C W, et al. Plasma levels of endothelial cell-specific molecule-1 as a potential biomarker of oral cancer progression[J]. Int J Med Sci, 2017, 14(11): 1094-1100. doi: 10.7150/ijms.20414
[18]	裴家强, 游波, 游凯, 等. PET/CT联合血清HE4、ESM-1在肺癌诊断中的应用价值[J]. 河北医药, 2020, 42(14): 2125-2128. https://www.cnki.com.cn/Article/CJFDTOTAL-HBYZ202014010.htm
[19]	李锐, 李晓丽. 甲状腺癌患者癌组织中CD34、增殖细胞核抗原和内皮细胞特异分子-1的表达及意义[J]. 中国老年学杂志, 2018, 38(16): 3881-3883. doi: 10.3969/j.issn.1005-9202.2018.16.017
[20]	罗宝洋, 杨勇, 段云飞, 等. 术前C反应蛋白和清蛋白比值对可切除胰腺癌患者预后的影响[J]. 中华外科杂志, 2018, 5(9): 712-717. http://med.wanfangdata.com.cn/Paper/Detail?dbid=WF_QK&id=PeriodicalPaper_zhwk201809014
[21]	张璐, 张莉, 李昌平. CD64指数和可溶性髓系细胞触发受体1对结肠癌术后感染的诊断价值[J]. 中华医院感染学杂志, 2019, 29(14): 2162-2166. http://www.cnki.com.cn/Article/CJFDTotal-ZHYY201914021.htm
[22]	LIU Z Q, JIN K Z, GUO M, et al. Prognostic value of the CRP/alb ratio, a novel inflammation-based score in pancreatic cancer[J]. Ann Surg Oncol, 2017, 24(2): 561-568. doi: 10.1245/s10434-016-5579-3
[23]	张大为, 张桂铭, 刘勇. 局部进展期肾癌术前CRP/Alb比值对预后的价值[J]. 青岛大学学报: 医学版, 2020, 56(4): 413-416.
[24]	郭信伟, 冀胜军, 周绍兵, 等. 治疗前血液炎性标志物对食管鳞癌患者放化疗疗效及预后的影响[J]. 中华放射医学与防护杂志, 2019(3): 202-207. http://med.wanfangdata.com.cn/Paper/Detail?dbid=WF_QK&id=PeriodicalPaper_zhfsyxyfhzz98201903009
[25]	赵晓慧, 李爽. SEPT9基因甲基化、生长分化因子15、糖类抗原199与结直肠癌患者临床病理特征和预后的关系[J]. 实用临床医药杂志, 2021, 25(24): 52-56. doi: 10.7619/jcmp.20213287
[26]	魏智民, 孙玉发, 李刚, 等. 癌症相关性炎症与肿瘤微环境相关研究进展[J]. 中国肿瘤临床, 2018, 45(21): 1117-1121. doi: 10.3969/j.issn.1000-8179.2018.21.767

[1]	YUAN Li, XIA Rongming, GAO Yueqiao, MIAO Xiufang. Analysis of early neuropsychological development in 417 premature infants and its influencing factors[J]. Journal of Clinical Medicine in Practice, 2022, 26(9): 103-106. DOI: 10.7619/jcmp.20214875
[2]	MA Linghua, LI Jiangheng, ZHONG Liuyu, HUANG Yongquan, ZHU Maoling. Clinical characteristics of pregnant woman in advanced maternal age and effect of pregnancy tests for pregnancy risks[J]. Journal of Clinical Medicine in Practice, 2022, 26(9): 50-53. DOI: 10.7619/jcmp.20214722
[3]	LIU Yangyang, YOU Yan, QIN Aiping, MA Min. A case analysis of fetal limb-body wall syndrome[J]. Journal of Clinical Medicine in Practice, 2022, 26(4): 127-129. DOI: 10.7619/jcmp.20212343
[4]	FU Ping, WU Wencui. Value of ultrasonic measurement of fetal fetal nuchal translucency thickness in early pregnancy and its relationship with adverse pregnancy outcomes[J]. Journal of Clinical Medicine in Practice, 2021, 25(15): 93-97. DOI: 10.7619/jcmp.20211030
[5]	LUO Aihua, BAO Rong, WU Tiantian, ZHU Jianlin. Value of color Doppler flow imaging combined with fetal non-stress test in diagnosis of fetal distress[J]. Journal of Clinical Medicine in Practice, 2020, 24(20): 100-102,107. DOI: 10.7619/jcmp.202020028
[6]	YIN Xiaohui, ZHOU Weihong, SUN Zhixia, XIA Jianmei, LI Ji, WANG Hua. Effect of real-time four-dimensional color Doppler ultrasonography on diangnosis of prenatal development of fetus[J]. Journal of Clinical Medicine in Practice, 2018, (22): 74-76. DOI: 10.7619/jcmp.201822024
[7]	LI Yunduan, LIU Weiwu, XU Xiuying. Multivariate analysis of fetal growth restriction and its prevention measures[J]. Journal of Clinical Medicine in Practice, 2017, (1): 90-93. DOI: 10.7619/jcmp.201701027
[8]	TIAN Ying. Effects of different feeding methods on neonatal development and maternal rehabilitation[J]. Journal of Clinical Medicine in Practice, 2016, (4): 127-129. DOI: 10.7619/jcmp.201604039
[9]	ZHAO Chunhua, WANG Yuqi. Influence of hyperbilirubinemia on neonatal nerve behavior and intellectual development[J]. Journal of Clinical Medicine in Practice, 2016, (3): 88-90,94. DOI: 10.7619/jcmp.201603027
[10]	CAO Hongzhen, BIAN Min, LI Qin, SHEN Jianqiu. Value of color Dopper ultrasonic examination in monitoring fetal renal artery blood flow parameters of patients with pregnancy-inducedhypertension syndrome and fetal growth restriction[J]. Journal of Clinical Medicine in Practice, 2014, (17): 94-96. DOI: 10.7619/jcmp.201417029

Cited By

Cited by

Periodical cited type(7)

1.	张考珍，严燕艺，商明，关换琼，张爱珍. 高龄孕妇再生育出生缺陷情况及其影响因素分析. 中外医学研究. 2022(10): 139-142 .
2.	孟远霞. 责任亲情交互护理模式干预在新生儿出生缺陷产妇中的应用效果及对产妇产后生活质量的影响. 临床医学研究与实践. 2021(04): 174-176+182 .
3.	罗丽兰，吴岸晓，王丽婷. 胎儿先天性畸形的调查结果统计及危险因素分析. 中国优生与遗传杂志. 2021(01): 107-110 .
4.	李淑妮，许晨耘，伍芳芳，蔡容燕，李春蕾，韩丽珍. 海口市2016—2019年新生儿出生缺陷情况及相关影响因素分析. 实用预防医学. 2021(07): 881-884 .
5.	章历红，赵灵. 高龄孕产妇孕前及孕期检查现状及影响因素分析. 中国计划生育学杂志. 2021(08): 1563-1567 .
6.	俞鹏，邓晓龙，袁军. 2017—2020年泰州市新生儿出生缺陷发生率调查及特征观察. 中国妇幼健康研究. 2021(09): 1245-1249 .
7.	刘清玲，刘长娣，杨舒. 胎儿发生先天性畸形的数据比例及影响因素的Logistic回归分析. 中国优生与遗传杂志. 2020(08): 1017-1019 .

Other cited types(3)

Get Citation

PDF

XML

Article views (258) PDF downloads (11) Cited by(10)

Turn off MathJax

Article Contents

Abstract

References

Value of serum carbohydrate antigen 19-9, endothelial cell specific molecule 1 and C-reactive protein to albumin ratio in diagnosis and evaluating prognosis of colorectal cancer